loader image

Eos portfolio business ClinSpec DX focused on the early detection of cancer has received a major seven-figure funding injection

A University of Strathclyde spinout business focused on the early detection of cancer has received a major seven-figure funding injection.  Glasgow-based ClinSpec Diagnostics (ClinSpec Dx), which was spun out from the university’s department of pure and applied chemistry in 2016, has developed a way of detecting cancer at an early stage using a simple blood … Read more

Latest news

SEIS limit increased to £250k
03 October 2022
Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets
06 September 2022

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.